-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly Deferred Tax Assets, Gross history and growth rate from Q1 2023 to Q1 2024.
- Elite Pharmaceuticals Inc /Nv/ Deferred Tax Assets, Gross for the quarter ending March 31, 2024 was $24.3M, a 7.46% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)